Life threatening splenic rupture due to Rivaroxaban: A rare case

Author(s)	Dr. Pratik Mohan Bangi, Dr. Dr.Biaktluangi T, Dr. Balakeshwa Ramaiah, Dr. Thabit Ahmed
Country	India
Abstract	Rivaroxaban is a direct oral anticoagulant that selectively inhibits factor Xa by blocking thrombin production. It is mainly indicated for the treatment and prevention of venous thromboembolism and in patients with non-valvular atrial fibrillation. We present a 74- year-old female patient with complaints of abdominal pain, nausea, and 3 episodes of non- bilious vomiting and dyspnea. She is a known case of type 2 DM, SHTN, HFpEF, and paroxysmal atrial fibrillation, for which she has been taking tablet Rivaroxaban 15mg for 3 years. Computed tomography of the abdomen demonstrated a splenic hemostasis, due to which an emergency splenectomy was conducted without stopping rivaroxaban, which led to a major complication during the surgery.
Keywords	Keywords spleen hematoma, Rivaroxaban, spleen hemorrhage, ssplenic rupture, DOAC, case report
Field	Medical / Pharmacy
Published In	Volume 7, Issue 6, November-December 2025
Published On	2025-12-11
DOI	https://doi.org/10.36948/ijfmr.2025.v07i06.63034

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research